YIH
VBIV

Y-Intercept (HK)’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Y-Intercept (HK)’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-39,772
Closed -$131K – 1735
2023
Q2 		$131K Buy
+39,772
New +$120K 0.01% 1016
2023
Q1 		– Sell
-5,586
Closed -$65.5K – 1627
2022
Q4 		$65.5K Buy
+5,586
New +$98.5K 0.01% 908
2022
Q3 		– Sell
-1,821
Closed -$44K – 1345
2022
Q2 		$44K Buy
+1,821
New +$62K 0.01% 761

Other funds holding VBIV

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return